BTIG analyst Dane Leone sees new reason to step away from the sidelines on Kite Pharma Inc (NASDAQ:KITE), upgrading his rating from a …
Yesterday, drug maker Kite Pharma Inc (NASDAQ:KITE) disclosed the death of a patient who was treated with KTE-C19, the company’s CAR-T blood cancer drug, …
BTIG analyst Dane Leone weighs in on Ocular Therapeutix Inc (NASDAQ:OCUL), following the news that CFO Bradford Smith will step down from his position as …
In a research report released Thursday, BTIG analyst Dane Leone reiterated a Buy rating on shares of Celgene Corporation (NASDAQ:CELG) with a price …
This morning, Ocular Therapeutix Inc (NASDAQ:OCUL) announced the resubmission of a New Drug Application (NDA) to the FDA for Dextenza, a drug-device combination for …
bluebird bio Inc (NASDAQ:BLUE) shares are surging 25% after releasing interim results from the firm’s Phase 1 trial of its anti-BCMA CAR T …
In a research report released Friday, BTIG analyst Dane Leone reiterated a Buy rating on shares of Celgene Corporation (NASDAQ:CELG) with a price target …
Juno Therapeutics Inc (NASDAQ:JUNO) shares rose nearly 4% today after the journal Science Translational Medicine published a paper that showed encouraging results for patients …
In a research report released yesterday evening, BTIG analyst Dane Leone initiated coverage on shares of Juno Therapeutics Inc (NASDAQ:JUNO) with a Sell rating …
A meeting with bluebird bio Inc’s (NASDAQ:BLUE) leadership last week validified Dane Leone’s, an analyst at BTIG, confidence in the company. The meeting …
